Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Immune globulin subcutaneous, human
Every register, a page at a time. Strengths and packs are on each medicine’s page.
28 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Xembify | United States | 1GM MG/ML | Injection | Marketed | Grifols Therapeutics LLC |
| Xembify | United States | 2GM MG/ML | Injection | Marketed | Grifols Therapeutics LLC |
| Xembify | United States | 10GM MG/ML | Injection | Marketed | Grifols Therapeutics LLC |
| Xembify | United States | 4GM MG/ML | Injection | Marketed | Grifols Therapeutics LLC |
| Cutaquig | United States | 1G/6ML | Solution | Marketed | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| Cutaquig | United States | 8G/48ML | Solution | Marketed | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| Cutaquig | United States | 3.3G/20 ML | Solution | Marketed | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| Cutaquig | United States | 1.65G/10 ML | Solution | Marketed | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| Cutaquig | United States | 2G/12ML | Solution | Marketed | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| Cutaquig | United States | 4G/24ML | Solution | Marketed | Octapharma Pharmazeutika Produktionsges.m.b.H. |
| Hizentra | United States | 1G/5ML | Injection | Marketed | CSL Behring AG |
| Hizentra | United States | 4G/20ML | Injection | Marketed | CSL Behring AG |
| Hizentra | United States | 2G/10ML | Injection | Marketed | CSL Behring AG |
| Hizentra | United States | 10G/50ML | Injection | Marketed | CSL Behring AG |
| Hizentra | United States | 10G/50ML | Injection | Marketed | CSL Behring AG |
| Hizentra | United States | 4G/20ML | Injection | Marketed | CSL Behring AG |
| Hizentra | United States | 2G/10ML | Injection | Marketed | CSL Behring AG |
| Hizentra | United States | 1G/5ML | Injection | Marketed | CSL Behring AG |
| Cuvitru | United States | 10G/50ML | Injection | Marketed | Takeda Pharmaceuticals U.S.A., Inc. |
| Cuvitru | United States | 8G/40ML | Injection | Marketed | Takeda Pharmaceuticals U.S.A., Inc. |
| Cuvitru | United States | 4G/20ML | Injection | Marketed | Takeda Pharmaceuticals U.S.A., Inc. |
| Cuvitru | United States | 1G/5ML | Injection | Marketed | Takeda Pharmaceuticals U.S.A., Inc. |
| Cuvitru | United States | 2G/10ML | Injection | Marketed | Takeda Pharmaceuticals U.S.A., Inc. |
| Vivaglobin | United States | 160MG/ML | For Injection | Withdrawn | CSL Behring GmbH |
| Immune Serum Globulin (Human) | Canada | 18 % | Solution | Cancelled | Grifols Therapeutics LLC |
At a glance
- Registers
- 1
- Medicines
- 4
- Companies
- 1